SC 13G

Company

Phio Pharmaceuticals Corp.

Filed

October 10, 2018

Accession Number

0001104659-18-061341

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →